Gilles Brisson
Directeur/Membre du Conseil chez INNATE PHARMA
Fortune : 172 251 $ au 30/04/2024
Provenance du réseau au premier degré de Gilles Brisson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 47 | |
Ethypharm SAS
 Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.
9
| Subsidiary | Biotechnology | 9 |
| Public Company | Medical Specialties | 8 | |
Financière Verdi Iii
 Financière Verdi Iii Financial ConglomeratesFinance Financière Verdi III is an investment holding private company based in Paris, France. The French company functions as an investment holding company.
2
| Private Company | Financial Conglomerates | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gilles Brisson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| École des Hautes Études Commerciales de Paris | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Université d'Aix-Marseille | College/University | Chairman Graduate Degree Doctorate Degree | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Analyst | |
| VEXIM | Medical Specialties | Founder Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| TRANSGENE | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Director/Board Member Corporate Officer/Principal | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| NNIT A/S | Information Technology Services | Director/Board Member Corporate Officer/Principal | |
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Psilos Group Managers LLC
 Psilos Group Managers LLC Investment ManagersFinance Psilos Group Managers LLC (Psilos Group) is a venture capital firm founded in 1998 by Al S. Waxman, Steve M. Krupa and Lisa M. Suennen. The firm is headquartered in New York. | Investment Managers | Founder Private Equity Investor | |
| AB SCIENCE | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
Geoservices SA
 Geoservices SA Contract DrillingIndustrial Services Geoservices SA engages in the exploration and extraction of oil and petroleum. The company is headquartered in Clamart, France. | Contract Drilling | Director/Board Member Public Communications Contact | |
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| Innate Pharma, Inc. | Chairman Director/Board Member | ||
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca SAS
 AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Founder Private Equity Investor | |
| KAUFMAN & BROAD SA | Homebuilding | Director/Board Member Director/Board Member | |
| PAI Europe V GP Ltd. | Director/Board Member Director/Board Member | ||
| BASTIDE LE CONFORT MÉDICAL | Medical/Nursing Services | Director/Board Member Chairman | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| Philipps University of Marburg | College/University | Doctorate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| STENTYS | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Lyon | College/University | Undergraduate Degree Undergraduate Degree | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member | |
Biospace Lab SA
 Biospace Lab SA Electronic Equipment/InstrumentsElectronic Technology Biospace Lab SA develops and produces imaging tools. Its products include optical imaging systems and digital autoradiography solutions. The company was founded by Georges Charpak in 1989 and is headquartered in Nesles la Vallée, France. | Electronic Equipment/Instruments | Chief Executive Officer Founder | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Groupe Limagrain Holding SA
 Groupe Limagrain Holding SA Agricultural Commodities/MillingProcess Industries Groupe Limagrain Holding SA engages in agricultural production. It offers wheat, corn, maize, sunflower, rapeseed, tomato, carrot, melon, cauliflower, and pepper, as well as flower seeds. The company was founded in 1965 and is headquartered in Saint-Beauzire, France. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member | |
| Institut d’Administration des Entreprises | College/University | Graduate Degree Masters Business Admin | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree Graduate Degree | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Statistiques
Internationale
| France | 31 |
| Etats-Unis | 9 |
| Danemark | 4 |
| Belgique | 4 |
| Royaume-Uni | 4 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 458 |
| Corporate Officer/Principal | 176 |
| Chairman | 116 |
| Independent Dir/Board Member | 61 |
| Chief Executive Officer | 60 |
Relations les plus connectées
| Insiders | |
|---|---|
| Frédéric P. Stévenin | 67 |
| Anne-Sophie Herelle | 65 |
| Philippe Pouletty | 51 |
| Michel Maurice Paris | 38 |
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Xavier Moreno | 35 |
| Catherine Moukheibir | 29 |
| Al S. Waxman | 29 |
| Stéphane Boissel | 24 |
| Patrick J. Langlois | 23 |
| Jean Deleage | 23 |
| Ekaterina Smirnyagina | 21 |
| Frank Morich | 21 |
| Maïlys Ferrère | 21 |
| Frank Bulens | 20 |
- Bourse
- Insiders
- Gilles Brisson
- Connexions Sociétés
